Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

18 Apr 2007 07:01

ViaLogy PLC18 April 2007 Date: 18 April 2007 On behalf of: ViaLogy plc ("ViaLogy" or "the Company") For Immediate Release ViaLogy PLC Board Appointment LONDON, April 18, 2007 -- ViaLogy PLC (LSE: VIY), the AIM-quoted technologycompany, today announced the appointment of Mr. Shah Talukder as executivedirector of ViaLogy with immediate effect. In addition to his appointment tothe main Board, Mr Talukder has also been appointed President and ChiefExecutive Officer of ViaLogy's wholly-owned American subsidiary, ViaLogy LLC, ofPasadena, California. Mr. Talukder comes to ViaLogy from Cisco Systems, where he was General Managerof Cisco's Safety, Security and Systems Business Unit (S3BU) where heestablished a start-up culture. Within Cisco he developed the vision,strategy, and road map for the Interoperability and Collaboration System (IPICS)family of products and applications. The system enables personnel within thesame or different agencies to communicate across previously isolated radio, IPand non-IP networks by delivering information to various types of communicationsdevices. These could range from a radio, a telephone, and an IP phone to amobile phone and a computer. At Cisco, Mr. Talukder was also instrumental in working closely with customers,industry and technology leaders, research institutions and sensor vendors todefine a vision and strategy for the Sensor Policy Manager (SPM) as a frameworkfor sensor based rapid detection and response to greatly improve the quality andspeed of information dissemination. "I am very excited at the potential of ViaLogy and I am looking forward toleading and growing the team," said Mr. Talukder. "The breadth of technologiesdeveloped by the company is extremely impressive and has a wide range ofapplications. It has the potential to become a platform for sensor and networksub-system interoperability and provide a service delivery architecture based oncustomer specific needs in such areas as Enterprise Security and Operations,Defence, Connected Real Estate, Oil and Gas, Transportation, Home Land Security,Retail and Healthcare." Mr Talukder added: "Customers and industry at large are looking for scaleablesolutions to sensor based remote monitoring, emissions mitigation, greenenvironment, physical and border security. As an example customers globally,regardless of national boundaries, whom I have met and spoken to are keenlyinterested in enhancing their capabilities to remotely monitor and respond togreenhouse gas, seismic and motion sensors, biological agents or to detectpressure in oil or gas pipelines. They want to provide the appropriateinformation within seconds, based on policy and business rules governing theincident. The information could be send to specific PC laptops, cell phones,PDAs, IP Phones, TV or digital signage etc. and could be in the form ofstandards-based video, voice and sensor data". "We are delighted that Shah Talukder has agreed to join us," said Mr. MichaelKelly, the former banker and venture capitalist who spearheaded the mergerarrangements which gave ViaLogy a public quotation on the AIM last year. "At Cisco, Shah has built, managed, and mentored teams towards industryexcellence through product innovations and delivery of solutions and has createda start-up like culture which is reflected by the wide industry acceptance ofCisco IPICS." Mr. Kelly will remain on the board of ViaLogy PLC as a non-executive director. ViaLogy PLC's Chairman, Mr. Terry Bond, stated: "During the last five yearsViaLogy has successfully developed a range of network-centric, real-time signalprocessing technology platforms for sensor applications. We are now transformingViaLogy into a product and sales centric company. Shah Talukder is the idealperson to scale and develop the vision, strategy and focused execution needed tolead ViaLogy forward". For further information please contact: ViaLogy PLCTerry Bond, Chairman - ViaLogy PLC +44 (0)20 7869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 Seymour Pierce LimitedMark Percy / Liam O'Donoghue +44 (0)20 7107 8000 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defence andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Dec 20217:00 amRNSHalf-year Report
6th Dec 20217:00 amRNSNotice of Half-year results
18th Nov 20217:00 amRNSDPYD screening recommended in Spain
28th Oct 20217:00 amRNSRanger® Technology to be presented at Labroots
26th Oct 20217:00 amRNSHalf-year Trading update
29th Sep 20217:00 amRNSResult of AGM
28th Sep 20213:00 pmRNSAGM update
28th Sep 20217:00 amRNSAGM Statement
15th Sep 20217:00 amRNSShare option awards
1st Sep 20217:00 amRNSISO 15189:2012 accreditation received
1st Sep 20217:00 amRNSNotice of AGM and Annual Report 2021
19th Aug 202112:04 pmRNSCOVID-19 Surge testing contract
11th Aug 20217:01 amRNSEarn-out Milestone, Issue of Equity & TVR
11th Aug 20217:00 amRNSAudited Final results&unaudited Q1 business update
6th Aug 20217:00 amRNSConfirmation of Results Date
23rd Jul 20217:00 amRNSNotice of Results
1st Jul 202111:09 amRNSHolding(s) in Company
21st Jun 20217:00 amRNSSecond Strategic Partner for Coastal Genomics
18th Jun 20217:00 amRNSContract Award: DPYD testing kits for NHS Wales
17th Jun 20214:32 pmRNSExercise of Options
9th Jun 20217:00 amRNSMulti-year licence and supply agreement
21st May 20214:30 pmRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSDistribution Partnership
18th May 20217:00 amRNSLaunch of IONA Care NIPT service offering
17th May 20217:00 amRNSFurther testing service agreement for MHC
29th Apr 20217:00 amRNSFull year Trading update
26th Apr 20217:00 amRNSFurther National Microbiology Framework awards
19th Apr 20211:21 pmRNSFurther National Microbiology Framework contract
19th Apr 20217:00 amRNSNational Framework contract award
12th Apr 20217:00 amRNSEarn-out Milestone, Issue of Equity & TVR
6th Apr 20212:43 pmRNSTesting service agreement with MyHealthCheckedplc
6th Apr 20211:54 pmRNSAgreement with Boots for COVID-19 sample kits
29th Mar 20214:00 pmRNSCOVID-19 update
23rd Mar 20217:00 amRNSShare option exercises and awards
19th Mar 20217:00 amRNSTwin Pregnancy study published using IONA® Test
17th Mar 20217:00 amRNSAppointment of VP of Sales North America
11th Mar 20217:00 amRNSYourgene Genomic Services portfolio expansion
1st Mar 20217:00 amRNSFirst US Supply Agreement
22nd Feb 20217:00 amRNSPartnership with NPH
10th Feb 202110:51 amRNSCorrection: Director / PDMR Shareholding
10th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSTrading update
13th Jan 20217:00 amRNSDPYD screening recommended in Belgium
11th Jan 20217:00 amRNSClarigene® SARS-CoV-2 Product Update
8th Jan 20217:00 amRNSIssue of Share Options
24th Dec 20207:00 amRNSCOVID-19 update
17th Dec 20207:00 amRNSHalf-year Report
15th Dec 20207:00 amRNSNotice of Half-year Results
2nd Dec 20207:00 amRNSDPYD kits recommended by NHS England
2nd Dec 20207:00 amRNSGenomic testing service launch and Change of name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.